Anti-COLGALT1 / Collagen beta(1-O)galactosyltransferase 1

Adding 0.2 ml of distilled water will yield a concentration of 500 ug/ml. COLGALT1 antibody detects Collagen beta(1-O)galactosyltransferase 1, an enzyme that catalyzes the transfer of galactose to hydroxylysine residues in collagen. This post-translational modification is essential for proper collagen folding, stability, and secretion. COLGALT1 functions within the endoplasmic reticulum and Golgi apparatus and contributes to the biosynthesis of structurally mature collagen fibers. The COLGALT1 antibody is widely used in connective tissue, developmental, and fibrosis research to study collagen maturation, glycosylation, and extracellular matrix regulation.COLGALT1 is encoded by the COLGALT1 gene located on human chromosome 19p13.2. The protein is approximately 739 amino acids long and is a member of the galactosyltransferase family. It forms a functional complex with its homolog COLGALT2 and works sequentially with lysyl hydroxylase (PLOD family) enzymes to glycosylate hydroxylysine residues in collagen alpha chains. This process stabilizes triple helix formation and enhances collagen secretion and cross-linking.The COLGALT1 antibody detects an 85 kilodalton protein by western blot and shows perinuclear staining under immunofluorescence microscopy consistent with Golgi localization. COLGALT1 activity is required for the synthesis of type I, II, III, and IV collagens. Deficiency or mutation results in defective collagen glycosylation, leading to abnormal extracellular matrix assembly and diseases such as Ehlers-Danlos syndrome and osteogenesis imperfecta-like disorders.COLGALT1 expression is tightly regulated during development and tissue repair. Increased expression promotes collagen deposition in fibrotic tissues, whereas reduced expression leads to unstable collagen and tissue fragility. It also contributes to tumor stroma remodeling by enhancing extracellular matrix density and rigidity, influencing cancer cell migration and angiogenesis.As a key enzyme linking collagen biosynthesis and tissue integrity, COLGALT1 serves as a critical target for studying connective tissue disorders and fibrotic diseases. NSJ Bioreagents provides a validated COLGALT1 antibody optimized for its applications, supporting research into collagen glycosylation, fibrosis, and tissue regeneration.